Vor Biopharma Inc. SEC filings VOR
Vor Biopharma Inc. has 462 filings in SEC EDGAR's recent list, going back to Jul 10, 2020. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Jul 7, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Jul 7, 2026 | Jul 6, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 8, 2026 | Jun 8, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Mar 27, 2026 | Mar 26, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 2, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Dec 18, 2025 | Dec 15, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 9, 2025 | Dec 5, 2025 |
| 8-K |
Current report
Other events
|
Nov 12, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Nov 3, 2025 | Nov 2, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 28, 2025 | Oct 28, 2025 |
| 8-K |
Current report
Change to shareholder rights, Other events
|
Sep 17, 2025 | Sep 17, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 2, 2025 | Sep 2, 2025 |
| 8-K |
Current report
Officer or director change
|
Aug 27, 2025 | Aug 25, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Aug 27, 2025 | Aug 25, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 22, 2025 | Jul 16, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 10, 2025 | Jul 9, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended, Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Jun 26, 2025 | Jun 25, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 23, 2025 | May 22, 2025 |
| 8-K |
Current report
Officer or director change
|
May 20, 2025 | May 19, 2025 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change, Other events
|
May 8, 2025 | May 5, 2025 |
| 8-K |
Current report
Listing notice
|
Apr 25, 2025 | Apr 22, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 3, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 6, 2025 | Feb 3, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 8, 2025 | Jan 6, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Dec 27, 2024 | Dec 26, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 9, 2024 | Dec 9, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 30, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 5, 2024 | Sep 5, 2024 |
| 8-K |
Current report
Listing notice
|
Aug 30, 2024 | Aug 29, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 10, 2024 | Jun 4, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 28, 2024 | May 23, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 2, 2024 | Apr 30, 2024 |
| 8-K |
Current report
Other events
|
Jan 5, 2024 | Jan 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 9, 2023 | Jun 9, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 26, 2023 | May 26, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 14, 2023 | Apr 12, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 16, 2023 | Feb 16, 2023 |
| 8-K |
Current report
Material agreement
|
Dec 23, 2022 | Dec 23, 2022 |
| 8-K |
Current report
Agreement ended
|
Dec 14, 2022 | Dec 9, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Dec 7, 2022 | Dec 7, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 7, 2022 | Dec 7, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 29, 2022 | Nov 29, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2022 | Jun 14, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 14, 2022 | Apr 11, 2022 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Jun 17, 2021 | Jun 15, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Feb 9, 2021 | Feb 9, 2021 |
Showing 48 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- VOR (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Boston, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1817229
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.